Nivalis Therapeutics, Inc. (ALPN)
(Delayed Data from NSDQ)
$6.24 USD
-0.08 (-1.27%)
Updated May 3, 2019 03:59 PM ET
NA Value
NA Growth NA Momentum NA VGMEarnings News For ALPN
-
Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline
-
Alpine Immune Sciences, Inc. (ALPN) Q4 Earnings and Revenues Beat Estimates
-
Alpine Immune Sciences, Inc. (ALPN) Expected to Beat Earnings Estimates: Should You Buy?
-
Alpine Immune Sciences Reports Third Quarter 2023 Financial Results
-
Alpine Immune Sciences Reports Second Quarter 2023 Financial Results
-
Alpine Immune Sciences Reports First Quarter 2023 Financial Results
-
Alpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Lags Revenue Estimates
-
Alpine Immune Sciences Provides Corporate Update and Reports Fourth Quarter and Full Year 2022 Financial Results
-
Alpine Immune Sciences, Inc. (ALPN) Reports Q3 Loss, Misses Revenue Estimates
-
Alpine Immune Sciences Provides Corporate Update and Reports Third Quarter 2022 Financial Results
-
Alpine Immune Sciences, Inc. (ALPN) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
Alpine Immune Sciences, Inc. (ALPN) Reports Q1 Loss, Tops Revenue Estimates
-
Alpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Misses Revenue Estimates
-
Alpine Immune Sciences, Inc. (ALPN) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
-
Alpine Immune Sciences, Inc. (ALPN) Earnings Expected to Grow: What to Know Ahead of Q3 Release
-
Alpine Immune Sciences, Inc. (ALPN) Reports Q2 Loss, Tops Revenue Estimates
-
Will Alpine Immune Sciences, Inc. (ALPN) Report Negative Q2 Earnings? What You Should Know
-
Alpine Immune Sciences, Inc. (ALPN) Reports Q1 Loss, Lags Revenue Estimates
-
Earnings Preview: Alpine Immune Sciences, Inc. (ALPN) Q1 Earnings Expected to Decline
-
Alpine Immune Sciences, Inc. (ALPN) Reports Q4 Loss, Tops Revenue Estimates
-
Analysts Estimate Alpine Immune Sciences (ALPN) to Report a Decline in Earnings: What to Look Out for
-
Earnings Preview: Alpine Immune Sciences (ALPN) Q1 Earnings Expected to Decline
-
Analysts Estimate Alpine Immune Sciences (ALPN) to Report a Decline in Earnings: What to Look Out for